A Study to Evaluate the Safety and Efficacy of a New Silicone Hydrogel Contact Lens Design
NCT ID: NCT01449526
Last Updated: 2015-02-18
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
166 participants
INTERVENTIONAL
2011-08-31
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate the Product Performance of a New Silicone Hydrogel Contact Lens
NCT01873846
Silicone Hydrogel Soft Contact Lens 7-Day Extended Wear Basis
NCT02939950
A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens
NCT01412983
A Study to Evaluate a New Silicone Hydrogel Contact Lens
NCT01309893
Feasibility of a New Silicone Hydrogel Lens
NCT01131130
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
B&L Investigational Contact Lens
The Bausch + Lomb investigational silicone hydrogel contact lens
B&L Investigational Contact Lens
Lenses will be worn on a daily wear basis for 3 months, new lenses dispensed monthly.
B&L PureVision Contact Lens
The Bausch + Lomb PureVision silicone hydrogel contact lens
B&L PureVision Contact Lens
Lenses will be worn on a daily wear basis for 3 months, new lenses dispensed monthly.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
B&L Investigational Contact Lens
Lenses will be worn on a daily wear basis for 3 months, new lenses dispensed monthly.
B&L PureVision Contact Lens
Lenses will be worn on a daily wear basis for 3 months, new lenses dispensed monthly.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects must be myopic, and wear contact lenses in each eye.
* Subjects must be adapted soft contact lens wearers and agree to wear their study lenses on a daily wear basis for approximately 3 months.
Exclusion Criteria
* Subjects with any systemic disease currently affecting ocular health or which in the Investigator's opinion may have an effect on ocular health during the course of the study.
* Subjects using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
* Subjects with an active ocular disease or who are using any ocular medication.
* Subjects with any grade 2 or greater finding during the slit lamp examination.
* Subjects with corneal infiltrates, of ANY GRADE, are not eligible.
* Subjects with any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
* Subjects who are allergic to any component in the study care products.
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bausch & Lomb Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Steffen, OD, MS
Role: STUDY_DIRECTOR
Bausch & Lomb Incorporated
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
661
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.